Published 1999 | Version v1
Miscellaneous Open

131I MIBG therapy of residual and/or recurrent medullary thyroid carcinoma (MTC)

  • 1. Medical Univ., Debrecen (Hungary). PET Centre
  • 2. National Institute of Oncology, Budapest (Hungary)

Description

The purpose of the study is to assess the value of high-dose MIBG treatment in 21 patients with residual and/or recurrent MTC. It was found that MIBG treatment exerts a temporary positive therapeutic effect on residual and/or recurrent MTC. (R.P.)

Files

30054495.pdf

Files (137.4 kB)

Name Size Download all
md5:c291197414859701c7ddcfa27f5fe9e9
137.4 kB Preview Download
Part of:
4. Congress of the Hungarian Radiotherapy Society

Additional details

Publishing Information

Imprint Title
4. Congress of the Hungarian Radiotherapy Society
Imprint Pagination
58 p.
Journal Page Range
p. 13
Report number
INIS-HU--003

Conference

Title
4. Congress of the Hungarian Radiotherapy Society
Original Conference Title
A Magyar Sugarterapias Tarsasag 4. kongresszusa
Dates
15-16 May 1999
Place
Szombathely (Hungary)

Optional Information